Nova Tirzepatide Review: $210 a Month All-In, and Why That Is a Floor (2026)

Nova quotes $210 a month, all in for its compounded weekly tirzepatide injection, with medication, shipping and the $99 monthly Nova Care membership inside a single number. That figure is public on the product page and served live from the company's own pricing endpoint. It is also a floor, because the words above it are Starting at, and Nova says the final cost depends on the dose a provider prescribes.¹

What the $210 does not settle

No dose-to-price table exists on any Nova surface, including the public pricing endpoint we read directly. A reader can therefore learn the entry price, and cannot learn the maintenance price, which is the one that matters after titration. That is why we give Nova no sortable monthly figure, and our tirzepatide dosage chart shows how far a dose usually travels. The oral daily microdose is quoted the same way, at $174 a month.

Three price sets, live at once

The hero and the pricing endpoint say $210, while the FAQ accordion on that same page is headed "What does the $279/mo include?", and its own arithmetic — $99 for the membership plus $180 for medication — lands on $279 instead. A third set sits in the site's script bundle as As low as $279/mo. The pricing page puts its floor under the heading "Plus Your Medication" and says medication is billed separately, while the product page for that same item says medication is included.

Who is behind Nova

The operator is NovaCure LLC, a Texas-governed management company whose terms say it does not practice medicine. It names Dr. Micah Craig, MD as medical director, a board-certified internal medicine physician, and it states its pharmacy class outright as 503A with no 503B claim anywhere. No compounding pharmacy and no medical group is named, and the site publishes no phone number. This is not Nova MD, a different company on a different domain, reviewed on its own page here.

The brand-vs-compounded question

Nova dispenses compounded tirzepatide, prepared under Section 503A rather than manufactured as an approved finished product. Our guide to whether compounded tirzepatide is still legal in 2026 sets out what that distinction now carries.

How the care model holds up

Nova serves 49 states and excludes California, stated in its footer and its telehealth consent. A live page still tells readers that care comes from professionals licensed in Texas and Florida, contradicting the 49-state line in the footer of that very same page. The sharper tension is financial, because the pricing page promises you are only charged if a licensed provider prescribes treatment, while the refund policy keeps membership and consultation fees once the clinical review is done, including where the provider declines to prescribe.

Does the drug work? (Separate from the provider)

Judge a seller on price, disclosure and oversight; judge the molecule on its trials. Tirzepatide's are strong, at around 15% to 21% of body weight over 72 weeks in SURMOUNT-1² and better than semaglutide when the two met directly in SURMOUNT-5³. Those results came from the branded drug at approved doses, not from a compounded copy.

The honest verdict

Nova does several things well: one all-in number, a named medical director, a pharmacy class stated without hedging. What it will not tell you is what you will pay at a maintenance dose, and until it publishes that, $210 is an advertisement rather than a budget. Oria Meds is the mirror image at $369 a month, a firm figure sold as the same price at all dosage levels but buried behind a long intake. SexyMD is also $369 month to month, and its headline gap runs the other way, since its banners quote the $299 rate that needs a 48-week commitment. The ranked best tirzepatide providers list sorts the field on what each one will commit to.